000 01506 a2200445 4500
005 20250513132741.0
264 0 _c19980106
008 199801s 0 0 eng d
022 _a0735-7907
024 7 _a10.3109/07357909709047595
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoffman, M
245 0 0 _aA pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain.
_h[electronic resource]
260 _bCancer investigation
_c1997
300 _a542-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdministration, Oral
650 0 4 _aAnalgesics, Opioid
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMorphine
_xadministration & dosage
650 0 4 _aMorphine Derivatives
_xmetabolism
650 0 4 _aNeoplasms
_xcomplications
650 0 4 _aPain
_xdrug therapy
650 0 4 _aPain Measurement
700 1 _aXu, J C
700 1 _aSmith, C
700 1 _aFanelli, C
700 1 _aPascal, V
700 1 _aDegaetano, C
700 1 _aMeenan, G
700 1 _aLehrer, M
700 1 _aLesser, M
700 1 _aCitron, M
773 0 _tCancer investigation
_gvol. 15
_gno. 6
_gp. 542-7
856 4 0 _uhttps://doi.org/10.3109/07357909709047595
_zAvailable from publisher's website
999 _c9382238
_d9382238